<DOC>
	<DOCNO>NCT01518972</DOCNO>
	<brief_summary>The purpose study determine whether drug prazosin effective treatment alcohol dependency symptom Posttraumatic Stress Disorder ( PTSD ) .</brief_summary>
	<brief_title>Prazosin Alcohol Dependence Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Background : Alcohol dependence ( AD ) biologically , genetically base disease , yet majority clinically accept treatment behaviorally psychosocially base . PTSD alcohol use disorder ( AUDs ) commonly co-occur . This comorbidity associate severe clinical impairment , short time relapse , treatment recidivism , overall great use treatment service , great treatment cost . Neuropharmacology alcohol prazosin : Emerging pre-clinical evidence show noradrenergic system involve brain process relevant AD , arousal , reinforcement , stress responsivity . However , virtually work date attempt translate knowledge clinically effective biological intervention . The investigator adopt novel , promising strategy reduce adrenergic activity block noradrenaline bind post-synaptic alpha-1 receptor via non-selective , alpha-1 antagonist , prazosin . Preclinical study demonstrate prazosin decrease reinstatement alcohol consumption , preliminary clinical data suggest prazosin reduces alcohol use human AD reduce PTSD-related nightmare symptom , though tested individual comorbid AD PTSD . Prazosin , FDA approve treat hypertension , typically side effect , inexpensive . Design : Randomized double-blind placebo-controlled clinical trial . Participants : 60 individual AD PTSD ( 25 % woman ) state goal abstain alcohol use . Intervention : Either prazosin titrate per study protocol match placebo 6 week Medical Management ( MM ) base COMBINE Study procedures final study visit two week medication discontinuation . Measures : The primary outcome alcohol use 12-week medication phase study report crave time period . Daily , prompt Interactive Voice Response ( IVR ) telephone monitor do throughout 8-week study assess primary outcome provide information affect medication adherence . Such daily monitoring provide accurate report alcohol use standard retrospective outcome measure . Analyses : Hierarchical linear model test main effect prazosin+MM versus placebo+MM alcohol use PTSD symptom time , evaluate whether reduction PTSD mediate effect prazosin . Findings date : The investigator enrol 30 participant 19 meet initial screen criterion randomize overall . Since last continue review investigator enrol 24 randomized 15 . Of 24 participant enrol , five veteran four randomize . Since last continue review , two serious adverse event . In case institutional review board ( IRB ) review determine probably unrelated study . Enrollment continue . Public health implication : There paucity safe , tolerable , inexpensive , efficacious drug currently available treatment AD PTSD . Should investigators find prazosin lead reduce alcohol use PTSD symptom severity relative placebo , clinicians additional tool help people PTSD dependent alcohol make crucial change life .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>Current primary DSMIV diagnosis alcohol dependence ( AD ) Current DSMIV diagnosis PTSD Heavy drinking last 30 day At least 18 year age Good general medical health ( see Exclusion Criteria ) Capacity provide inform consent English fluency Psychiatric/behavioral : psychiatric disorder require medication antidepressant currently take disulfiram , acamprosate , naltrexone plan take medication 12week medication phase study current dependence psychoactive substance nicotine cannabis current diagnosis opioid abuse , use opioid containing medication benzodiazepine previous month , UDA positive opioids , benzodiazepine , sedative hypnotic Medical : significant acute chronic medical illness ; woman pregnant , nurse infant ( ) , childbearing potential use contraceptive method judge study physician PA effective sign symptom alcohol withdrawal time initial consent legal involvement could interfere study treatment individual court order treatment eligible participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Abuse</keyword>
	<keyword>Use</keyword>
	<keyword>Disorder</keyword>
	<keyword>Dependence</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Alcoholic</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Prazosin</keyword>
	<keyword>Drug</keyword>
	<keyword>Medicine</keyword>
	<keyword>Medication</keyword>
	<keyword>Treatment</keyword>
	<keyword>Study</keyword>
	<keyword>Placebo</keyword>
	<keyword>Medical</keyword>
	<keyword>Management</keyword>
	<keyword>Craving</keyword>
	<keyword>Consumption</keyword>
	<keyword>Binge</keyword>
	<keyword>Drinking</keyword>
	<keyword>Drink</keyword>
	<keyword>Heavy</keyword>
	<keyword>PTSD</keyword>
	<keyword>Trauma</keyword>
	<keyword>Post</keyword>
	<keyword>Posttraumatic</keyword>
</DOC>